Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL544239 | 0.94 | TLR7 (0.61) | TLR7TLR8 | |
| SCHEMBL2744508 | 0.89 | TLR7 (0.57) | TLR7TLR8 | |
| SCHEMBL2744527 | 0.88 | TLR7 (0.54) | TLR7TLR8 | |
| SCHEMBL2744179 | 0.87 | TLR7 (0.56) | TLR7TLR8 | |
| SCHEMBL483278 | 0.87 | TLR7 (0.68) | TLR7TLR8 | |
| SCHEMBL30345824 | 0.87 | TLR7 (0.68) | TLR7TLR8 | |
| SCHEMBL29421427 | 0.86 | TLR7 (0.73) | TLR7TLR8 | |
| SCHEMBL1616712 | 0.86 | TLR7 (0.73) | TLR7TLR8 | |
| SCHEMBL29421426 | 0.86 | TLR7 (0.73) | TLR7TLR8 | |
| Water SCHEMBL4531043 | 0.85 | TLR7 (0.72) | TLR7TLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1651190-B1 | FORMULATIONS CONTAINING AN IMMUNE RESPONSE MODIFIER | 3M INNOVATIVE PROPERTIES CO (US) | 2012-09-19 | — | — | EP | claimed |
| EP-1651190-A4 | FORMULATIONS CONTAINING AN IMMUNE RESPONSE MODIFIER | 3M INNOVATIVE PROPERTIES CO (US) | 2009-07-15 | — | — | EP | claimed |
| US-20070292456-A1 | Formulations Containing an Immune Response Modifier | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-12-20 | — | — | US | claimed |
| EP-1651190-A2 | FORMULATIONS CONTAINING AN IMMUNE RESPONSE MODIFIER | 3M Innovative Properties Company (US) | 2006-05-03 | — | — | EP | claimed |
| WO-2005016275-A2 | FORMULATIONS CONTAINING AN IMMUNE RESPONSE MODIFIER | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-02-24 | — | — | WO | claimed |
| EP-1651190-B1 | FORMULATIONS CONTAINING AN IMMUNE RESPONSE MODIFIER | 3M INNOVATIVE PROPERTIES CO (US) | 2012-09-19 | — | — | EP | disclosed |
| US-8221771-B2 | Formulations containing an immune response modifier | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-07-17 | — | — | US | disclosed |
| EP-1651190-A4 | FORMULATIONS CONTAINING AN IMMUNE RESPONSE MODIFIER | 3M INNOVATIVE PROPERTIES CO (US) | 2009-07-15 | — | — | EP | disclosed |
| US-20070292456-A1 | Formulations Containing an Immune Response Modifier | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-12-20 | — | — | US | disclosed |
| EP-1651190-A2 | FORMULATIONS CONTAINING AN IMMUNE RESPONSE MODIFIER | 3M Innovative Properties Company (US) | 2006-05-03 | — | — | EP | disclosed |
| US-20060051374-A1 | Compositions and methods for mucosal vaccination | 3M INNOVATIVE PROPERTIES COMPANY | 2006-03-09 | — | — | US | disclosed |
| WO-2005016275-A2 | FORMULATIONS CONTAINING AN IMMUNE RESPONSE MODIFIER | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-02-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070292456-A1 | Formulations Containing an Immune Response Modifier | IFNG, IRF3, ICOS | TLR7 18/4885TLR8 28/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.